Increasing demand for imaging systems sparked a 7% jump in orders for healthcare equipment at Philips in the third quarter. Much of the gain came from customers in North America, where orders grew by 11% compared with 2% growth elsewhere in the world, leading to hopeful speculation that the extended lull in equipment purchases may finally be coming to a close.
Increasing demand for imaging systems sparked a 7% jump in orders for healthcare equipment at Philips in the third quarter. Much of the gain came from customers in North America, where orders grew by 11% compared with 2% growth elsewhere in the world, leading to hopeful speculation that the extended lull in equipment purchases may finally be coming to a close.
Pierre-Jean Sivignon, Philips chief financial officer, said the company expected and benefitted from large multiyear deals in the first half of the year. Hospitals continue to focus on lowering their operating costs and managing their return on investment capital, he said.
"[But] for those with relatively strong balance sheets, availability of credit has eased," he said.
The third quarter, for which Philips' results were released earlier this week, is the latest in a string of positive quarters for the company that began in Q1 of this year. Each successive quarter for 2010 has edged higher, according to data released by the firm. Best of all, Philips said it expects the market for U.S. imaging systems during the rest of this year and beyond to continue growing by 2% to 4%.
At this rate, however, it will take awhile for the market to rebound to the heights of a couple years ago, and there are no signs yet that demand will dramatically grow in the U.S. The problem, according to Sivignon, is the continuing uncertainty surrounding healthcare reform, particularly about possible taxes on healthcare equipment.
This year's healthcare reform legislation calls for taxes on the sale of new equipment to help fund the extra costs associated with expanded coverage. Exactly how much and who would pay these taxes remains uncertain, but current analyses indicate that manufacturers may be liable for a 2.3% excise tax on most, if not all, medical device sales beginning Jan. 1, 2013. This excise tax may be applicable to leased equipment as well as equipment acquired outright.
Philips' hopes for continuing growth in healthcare may depend on customers outside the U.S. and Europe.
"We see robust demand in the emerging markets, as more investments continue to be directed at these markets," Sivignon said.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.